VIROMETIX
DEAD

Serial Number

79257237

Owner

Virometix AG

Attorney

Trina A. Longo

Filing Date

Feb 25, 2019

Add to watchlist:

No watchlists yet
View on USPTO

VIROMETIX Trademark

Serial Number: 79257237

VIROMETIX is a trademark filed by Virometix AG on February 25, 2019. The trademark is classified under Class 42 (Computer & Scientific). The application is currently no longer active.

Owner Contact Info

Virometix AG

Wagistrasse 14

Entity Type: 25

Trademark Details

Filing Date

February 25, 2019

Registration Date

Not Registered

Goods & Services

Scientific and technological services, namely, scientific and technological research, analysis, and testing for the prevention and treatment of diseases, in particular for infectious, respiratory, oncological, and chronic diseases, as well as scientific research and design services for the prevention and treatment of diseases, in particular infectious, respiratory, oncological, and chronic diseases; industrial analysis and industrial research services, namely, industrial research and analysis for the prevention and treatment of diseases, in particular infectious, respiratory, oncological and chronic diseases; providing information and data on the subject of scientific and technological research and development for the prevention and treatment of diseases, in particular infectious, respiratory, oncological and chronic diseases; scientific and technological services, namely, scientific research, analysis, and testing in the field of development of vaccines, immunotherapeutic, immunological, pharmaceutical and diagnostic products, especially vaccines, immunotherapeutic and pharmaceutical and synthetic products like viruses, mimetic antigens and immunotherapeutic and synthetic products as well as nano-medicinal products, in particular for the prevention and treatment of infectious, respiratory, oncological and chronic diseases, as well as scientific and technological services, namely, scientific research, analysis, and testing in the field of discovering, development and formulation of medicinal products, product design and chemical synthesis, especially for vaccines, immunotherapeutic and pharmaceutical and synthetic products like viruses, mimetic antigens and immunotherapeutic and synthetic products as well as nano-medicinal products; scientific and technological services, namely, scientific research, analysis, and testing in the field of development of vaccines, immunotherapeutic, immunological, pharmaceutical and diagnostic products for the transfer of genetic material and for gene delivery, especially vaccines, immunotherapeutic and pharmaceutical and synthetic products like viruses, mimetic antigens and immunotherapeutic and synthetic products for the transfer of genetic material and for gene delivery, in particular for the prevention and treatment of infectious, respiratory, oncological and chronic diseases

Filing History

FINAL DECISION TRANSACTION PROCESSED BY IB
Jul 31, 2021 FINT
FINAL DISPOSITION NOTICE SENT TO IB
Jul 13, 2021 FICS
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Jul 13, 2021 FICR
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Oct 17, 2020 OPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Sep 30, 2020 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Sep 30, 2020 OPNR
ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Jul 13, 2020 MAB2
ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Jul 13, 2020 ABN2
NOTIFICATION OF FINAL REFUSAL EMAILED
Dec 30, 2019 GNFN
FINAL REFUSAL E-MAILED
Dec 30, 2019 GNFR
FINAL REFUSAL WRITTEN
Dec 30, 2019 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Dec 6, 2019 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Dec 5, 2019 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Dec 5, 2019 TROA
REFUSAL PROCESSED BY IB
Jun 22, 2019 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Jun 6, 2019 RFCS
REFUSAL PROCESSED BY MPU
Jun 6, 2019 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
May 15, 2019 RFCR
NON-FINAL ACTION WRITTEN
May 14, 2019 CNRT
APPLICATION FILING RECEIPT MAILED
May 14, 2019 MAFR
ASSIGNED TO EXAMINER
May 9, 2019 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
May 9, 2019 NWOS
LIMITATION FROM ORIGINAL APPLICATION ENTERED
May 8, 2019 LIMI
SN ASSIGNED FOR SECT 66A APPL FROM IB
Apr 25, 2019 REPR